Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 HilleVax Lays Off 40% of Workforce | Contract Pharma

What are you searching for?

Sign in
Breaking News

HilleVax Lays Off 40% of Workforce

Aims to preserve cash while maintaining core capabilities.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

HilleVax, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, has announced a workforce reduction of 40%—or about 41 employees—to reduce its operating expenses.
 
The layoffs are intended to preserve cash while maintaining core capabilities as the company explores the potential for continued development of its HIL-214 and HIL-216 norovirus vaccine candidates as well as business development-related activities for these vaccine candidates.
 
Read about more layoffs in the biopharma sector.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters